A serotonergic mechanism is involved in the pro-cognitive effect of AM6545 treatment in a mouse model of fragile X syndrome
Lucía de los Reyes‐Ramírez, Araceli Bergadà‐Martínez, Sara Martínez‐Torres, Irene Martínez‐Gallego, Pilar Losada-Ruiz, Silvia Arboleya, Antonio González-Matute, Miguel Gueimonde, Rafael J. Maldonado, Antonio Rodríguez Moreno, Andrés Ozaita
This study shows that AM6545 treatment improves cognitive deficits in FX mice by modulating serotonergic receptors and gut microbiota.
Translational Psychiatry · Aug 20, 2026Peer-reviewedAnimal Behavior & Cognition